As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

Many biological functions are regulated by the switching on and off of mechanisms triggered by the matching of a keyhole ...

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

Get the latest Sai Life Sciences share price today on NSE & BSE. Explore Sai Life Sciences stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

The research by Turkish scientists who developed the 'invisible keys' technology in drug design offers a critical opportunity ...

“Designing treatments unique to individual patients has always been the promised goal of personalized medicine. After 25 years the FDA has, for the first time, outlined a framework to facilitate these ...

How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.

Continuing with the rare disease theme (Rare Disease Day is Feb 28), Elisabeth Gardiner of Tevard Biosciences explains in a video interview that research into ultra-rare conditions continues to yield ...

The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...

MSD's Chief AI Officer, Anton Groom, highlights AI's transformative role in drug discovery. AI models like TEDDY and KERMT ...